Annamaria Frustaci

34PUBLICATIONS
144CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Sep 16, 2026
Real-World Determinants of Treatment Selection in Frontline Chronic Lymphocytic Leukemia: The FIRST-CLL Study.

|Mar 09, 2026
Renal dysfunction in symptomatic Waldenström macroglobulinaemia: A nationwide Italian multicentre study.

Nicolò Danesin, Francesco Autore, Anna Maria Frustaci

|Jan 07, 2026
Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort.

Enrica Antonia Martino, Annalisa Pitino, Ernesto Vigna

|Dec 29, 2025
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study.

Ernesto Vigna, Enrica Antonia Martino, Annalisa Pitino

|Jun 12, 2025
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study.

Alberto Fresa, Idanna Innocenti, Annamaria Tomasso

|Apr 16, 2025
International consensus statement on diagnosis, evaluation, and research of Richter transformation: the ERIC recommendations.

Adam S Kittai, Monia Marchetti, Othman Al-Sawaf

Pageof 6

Frequent Collaborators

12 joint publications

Luca Laurenti

9 joint publications

Andrea Visentin

9 joint publications

Riccardo Moia

7 joint publications

Marta Coscia